• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对人乳头瘤病毒(HPV)阳性和阴性的头颈部鳞状细胞癌以及配对的正常黏膜进行分析,发现细胞周期蛋白D1失调及细胞周期蛋白D2的代偿作用。

Analysis of HPV-Positive and HPV-Negative Head and Neck Squamous Cell Carcinomas and Paired Normal Mucosae Reveals Cyclin D1 Deregulation and Compensatory Effect of Cyclin D2.

作者信息

Novotný Jiří, Bandúrová Veronika, Strnad Hynek, Chovanec Martin, Hradilová Miluše, Šáchová Jana, Šteffl Martin, Grušanović Josipa, Kodet Roman, Pačes Václav, Lacina Lukáš, Smetana Karel, Plzák Jan, Kolář Michal, Vomastek Tomáš

机构信息

Laboratory of Genomics and Bioinformatics, Institute of Molecular Genetics of the Czech Academy of Sciences, 142 20 Prague, Czech Republic.

Department of Informatics and Chemistry, Faculty of Chemical Technology, University of Chemistry and Technology, 160 00 Prague, Czech Republic.

出版信息

Cancers (Basel). 2020 Mar 26;12(4):792. doi: 10.3390/cancers12040792.

DOI:10.3390/cancers12040792
PMID:32224897
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7226528/
Abstract

Aberrant regulation of the cell cycle is a typical feature of all forms of cancer. In head and neck squamous cell carcinoma (HNSCC), it is often associated with the overexpression of cyclin D1 (). However, it remains unclear how expression changes between tumor and normal tissues and whether human papillomavirus (HPV) affects differential expression. Here, we evaluated the expression of D-type cyclins in a cohort of 94 HNSCC patients of which 82 were subjected to whole genome expression profiling of primary tumors and paired normal mucosa. Comparative analysis of paired samples showed that was upregulated in 18% of HNSCC tumors. Counterintuitively, was downregulated in 23% of carcinomas, more frequently in HPV-positive samples. There was no correlation between the change in D-type cyclin expression and patient survival. Intriguingly, among the tumors with downregulated , one-third showed an increase in cyclin D2 () expression. On the other hand, one-third of tumors with upregulated showed a decrease in . Collectively, we have shown that was frequently downregulated in HNSCC tumors. Furthermore, regardless of the HPV status, our data suggested that a change in expression was alleviated by a compensatory change in expression.

摘要

细胞周期的异常调控是所有癌症形式的典型特征。在头颈部鳞状细胞癌(HNSCC)中,它通常与细胞周期蛋白D1()的过表达相关。然而,其在肿瘤组织和正常组织之间的表达变化以及人乳头瘤病毒(HPV)是否影响差异表达仍不清楚。在此,我们评估了94例HNSCC患者队列中D型细胞周期蛋白的表达,其中82例患者接受了原发性肿瘤和配对正常黏膜的全基因组表达谱分析。配对样本的比较分析显示,18%的HNSCC肿瘤中 上调。与直觉相反,23%的癌组织中 下调,在HPV阳性样本中更常见。D型细胞周期蛋白表达的变化与患者生存率之间没有相关性。有趣的是,在 下调的肿瘤中,三分之一显示细胞周期蛋白D2()表达增加。另一方面, 上调的肿瘤中有三分之一显示 表达下降。总体而言,我们已表明在HNSCC肿瘤中 经常下调。此外,无论HPV状态如何,我们的数据表明 表达的变化通过 表达的代偿性变化得到缓解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3526/7226528/05a4a5c804b2/cancers-12-00792-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3526/7226528/64cddab80b75/cancers-12-00792-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3526/7226528/5abe56a45796/cancers-12-00792-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3526/7226528/d6cac0733427/cancers-12-00792-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3526/7226528/a1bc00caaa0d/cancers-12-00792-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3526/7226528/b0204a5553a8/cancers-12-00792-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3526/7226528/05a4a5c804b2/cancers-12-00792-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3526/7226528/64cddab80b75/cancers-12-00792-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3526/7226528/5abe56a45796/cancers-12-00792-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3526/7226528/d6cac0733427/cancers-12-00792-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3526/7226528/a1bc00caaa0d/cancers-12-00792-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3526/7226528/b0204a5553a8/cancers-12-00792-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3526/7226528/05a4a5c804b2/cancers-12-00792-g006.jpg

相似文献

1
Analysis of HPV-Positive and HPV-Negative Head and Neck Squamous Cell Carcinomas and Paired Normal Mucosae Reveals Cyclin D1 Deregulation and Compensatory Effect of Cyclin D2.对人乳头瘤病毒(HPV)阳性和阴性的头颈部鳞状细胞癌以及配对的正常黏膜进行分析,发现细胞周期蛋白D1失调及细胞周期蛋白D2的代偿作用。
Cancers (Basel). 2020 Mar 26;12(4):792. doi: 10.3390/cancers12040792.
2
Fibroblast growth factor (FGF), FGF receptor (FGFR), and cyclin D1 (CCND1) DNA methylation in head and neck squamous cell carcinomas is associated with transcriptional activity, gene amplification, human papillomavirus (HPV) status, and sensitivity to tyrosine kinase inhibitors.成纤维细胞生长因子(FGF)、FGF 受体(FGFR)和细胞周期蛋白 D1(CCND1)在头颈部鳞状细胞癌中的 DNA 甲基化与转录活性、基因扩增、人乳头瘤病毒(HPV)状态和对酪氨酸激酶抑制剂的敏感性有关。
Clin Epigenetics. 2021 Dec 21;13(1):228. doi: 10.1186/s13148-021-01212-4.
3
[The relationship between human papillomavirus and cyclin D1 gene amplification in squamous cell carcinomas of the head and neck].[人乳头瘤病毒与头颈部鳞状细胞癌中细胞周期蛋白D1基因扩增的关系]
Acta Otorrinolaringol Esp. 2005 Nov;56(9):428-33. doi: 10.1016/s0001-6519(05)78642-8.
4
CCND1 amplification and cyclin D1 immunohistochemical expression in head and neck squamous cell carcinomas.头颈部鳞状细胞癌中的CCND1扩增及细胞周期蛋白D1免疫组化表达
Clin Oral Investig. 2014 Jan;18(1):269-76. doi: 10.1007/s00784-013-0967-6. Epub 2013 Mar 15.
5
Amplification and expression of cyclin D genes (CCND1, CCND2 and CCND3) in human malignant gliomas.细胞周期蛋白D基因(CCND1、CCND2和CCND3)在人类恶性胶质瘤中的扩增与表达。
Brain Pathol. 1999 Jul;9(3):435-42; discussion 432-3. doi: 10.1111/j.1750-3639.1999.tb00532.x.
6
Distinctive Expression and Amplification of Genes at 11q13 in Relation to HPV Status with Impact on Survival in Head and Neck Cancer Patients.11q13基因的独特表达及扩增与HPV状态的关系及其对头颈癌患者生存的影响
J Clin Med. 2018 Dec 1;7(12):501. doi: 10.3390/jcm7120501.
7
Genetic alterations (amplification and rearrangement) of D-type cyclins loci in head and neck squamous cell carcinoma of Indian patients: prognostic significance and clinical implications.印度患者头颈部鳞状细胞癌中D型细胞周期蛋白基因座的遗传改变(扩增和重排):预后意义及临床影响
Diagn Mol Pathol. 2006 Mar;15(1):7-16. doi: 10.1097/00019606-200603000-00002.
8
Amplification of cyclin D1 in squamous cell carcinoma of the head and neck and the prognostic value of chromosomal abnormalities and cyclin D1 overexpression.头颈部鳞状细胞癌中细胞周期蛋白D1的扩增以及染色体异常和细胞周期蛋白D1过表达的预后价值。
Cancer. 1997 Jan 15;79(2):380-9.
9
Abnormal patterns of D-type cyclin expression and G1 regulation in human head and neck cancer.人类头颈癌中D型细胞周期蛋白表达及G1期调控的异常模式
Cancer Res. 1995 Feb 15;55(4):949-56.
10
Cyclin D1 abnormalities and tobacco exposure in head and neck squamous cell carcinoma.头颈部鳞状细胞癌中的细胞周期蛋白D1异常与烟草暴露
Head Neck. 1996 Nov-Dec;18(6):512-21. doi: 10.1002/(SICI)1097-0347(199611/12)18:6<512::AID-HED5>3.0.CO;2-5.

引用本文的文献

1
Genetic and Molecular Differences in Head and Neck Cancer Based on Smoking History.基于吸烟史的头颈癌的遗传和分子差异
JAMA Otolaryngol Head Neck Surg. 2025 Apr 1;151(4):379-388. doi: 10.1001/jamaoto.2024.5409.
2
Cyclin D1 expression in penile cancer.阴茎癌中细胞周期蛋白 D1 的表达。
Oncotarget. 2024 May 14;15:302-311. doi: 10.18632/oncotarget.28584.
3
Unravelling the heterogeneity of oral squamous cell carcinoma by integrative analysis of single-cell and bulk transcriptome data.通过单细胞和批量转录组数据的综合分析揭示口腔鳞状细胞癌的异质性。

本文引用的文献

1
Palbociclib and cetuximab in platinum-resistant and in cetuximab-resistant human papillomavirus-unrelated head and neck cancer: a multicentre, multigroup, phase 2 trial.帕博西尼联合西妥昔单抗治疗铂类耐药和西妥昔单抗耐药的人乳头瘤病毒阴性头颈部鳞癌:一项多中心、多队列、Ⅱ期临床试验。
Lancet Oncol. 2019 Sep;20(9):1295-1305. doi: 10.1016/S1470-2045(19)30405-X. Epub 2019 Jul 24.
2
Genetic Factors Associated with a Poor Outcome in Head and Neck Cancer Patients Receiving Definitive Chemoradiotherapy.接受根治性放化疗的头颈癌患者预后不良相关的遗传因素
Cancers (Basel). 2019 Mar 29;11(4):445. doi: 10.3390/cancers11040445.
3
Distinctive Expression and Amplification of Genes at 11q13 in Relation to HPV Status with Impact on Survival in Head and Neck Cancer Patients.
J Cell Mol Med. 2024 Feb;28(3):e18108. doi: 10.1111/jcmm.18108. Epub 2024 Jan 26.
4
Comprehensive analysis of single-cell and bulk RNA-sequencing data identifies B cell marker genes signature that predicts prognosis and analysis of immune checkpoints expression in head and neck squamous cell carcinoma.对单细胞和批量RNA测序数据的综合分析确定了可预测头颈部鳞状细胞癌预后的B细胞标记基因特征,并分析了免疫检查点的表达。
Heliyon. 2023 Nov 24;9(12):e22656. doi: 10.1016/j.heliyon.2023.e22656. eCollection 2023 Dec.
5
The Role of IL-6 in Cancer Cell Invasiveness and Metastasis-Overview and Therapeutic Opportunities.IL-6 在癌细胞侵袭和转移中的作用——概述和治疗机会。
Cells. 2022 Nov 21;11(22):3698. doi: 10.3390/cells11223698.
6
The Renaissance of Cyclin Dependent Kinase Inhibitors.细胞周期蛋白依赖性激酶抑制剂的复兴
Cancers (Basel). 2022 Jan 7;14(2):293. doi: 10.3390/cancers14020293.
7
Fibroblast growth factor (FGF), FGF receptor (FGFR), and cyclin D1 (CCND1) DNA methylation in head and neck squamous cell carcinomas is associated with transcriptional activity, gene amplification, human papillomavirus (HPV) status, and sensitivity to tyrosine kinase inhibitors.成纤维细胞生长因子(FGF)、FGF 受体(FGFR)和细胞周期蛋白 D1(CCND1)在头颈部鳞状细胞癌中的 DNA 甲基化与转录活性、基因扩增、人乳头瘤病毒(HPV)状态和对酪氨酸激酶抑制剂的敏感性有关。
Clin Epigenetics. 2021 Dec 21;13(1):228. doi: 10.1186/s13148-021-01212-4.
8
Identification of Immune-Related Risk Signatures for the Prognostic Prediction in Oral Squamous Cell Carcinoma.鉴定口腔鳞状细胞癌预后预测的免疫相关风险特征。
J Immunol Res. 2021 Aug 25;2021:6203759. doi: 10.1155/2021/6203759. eCollection 2021.
9
Human Papillomavirus and Cancers.人乳头瘤病毒与癌症
Cancers (Basel). 2020 Dec 15;12(12):3772. doi: 10.3390/cancers12123772.
11q13基因的独特表达及扩增与HPV状态的关系及其对头颈癌患者生存的影响
J Clin Med. 2018 Dec 1;7(12):501. doi: 10.3390/jcm7120501.
4
Prognostic significance of cell cycle-associated proteins p16, pRB, cyclin D1 and p53 in resected oropharyngeal carcinoma.p16、pRB、cyclin D1 和 p53 等细胞周期相关蛋白在切除的口咽癌中的预后意义。
J Otolaryngol Head Neck Surg. 2018 Sep 6;47(1):53. doi: 10.1186/s40463-018-0298-3.
5
CDKN2A Copy Number Loss Is an Independent Prognostic Factor in HPV-Negative Head and Neck Squamous Cell Carcinoma.CDKN2A基因拷贝数缺失是HPV阴性头颈部鳞状细胞癌的独立预后因素。
Front Oncol. 2018 Apr 4;8:95. doi: 10.3389/fonc.2018.00095. eCollection 2018.
6
An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics.TCGA 泛癌临床数据资源整合,推动高质量生存预后分析。
Cell. 2018 Apr 5;173(2):400-416.e11. doi: 10.1016/j.cell.2018.02.052.
7
The molecular landscape of head and neck cancer.头颈部癌症的分子图谱。
Nat Rev Cancer. 2018 May;18(5):269-282. doi: 10.1038/nrc.2018.11. Epub 2018 Mar 2.
8
Cell cycle proteins as promising targets in cancer therapy.细胞周期蛋白作为癌症治疗中有前景的靶点。
Nat Rev Cancer. 2017 Jan 27;17(2):93-115. doi: 10.1038/nrc.2016.138.
9
Phase I trial of palbociclib, a selective cyclin dependent kinase 4/6 inhibitor, in combination with cetuximab in patients with recurrent/metastatic head and neck squamous cell carcinoma.一项关于选择性细胞周期蛋白依赖性激酶4/6抑制剂帕博西尼联合西妥昔单抗治疗复发/转移性头颈部鳞状细胞癌患者的I期试验。
Oral Oncol. 2016 Jul;58:41-8. doi: 10.1016/j.oraloncology.2016.05.011. Epub 2016 May 28.
10
Complex heatmaps reveal patterns and correlations in multidimensional genomic data.复杂热图揭示多维基因组数据中的模式和相关性。
Bioinformatics. 2016 Sep 15;32(18):2847-9. doi: 10.1093/bioinformatics/btw313. Epub 2016 May 20.